Indeed, TNF-α inhibitors have been tested in several randomized controlled trials as anti-sepsis treatment but failed to show convincing positive effect in humans20,21, though it might be associated with lower risk of developing sepsis and fatal outcome after serious infection in RA patients22. The gene discussed is TNF; the disease is infection.